Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

N-(3,3-diphenylpropyl)-N-(2-hydroxy-2-methylpropyl)nitrous amide

● Auf Lager

Katalog-Nr.::	VE0021542
CAS-Nr.::	N/A
Summenformel::	C19H24N2O2
Molare Masse::	312.41 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu N-(3 | 3-diphenylpropyl)-N-(2-hydroxy-2-methylpropyl)nitrous amide

Parent drug

Lercanidipine

IUPAC-Name

N-(3, 3-diphenylpropyl)-N-(2-hydroxy-2-methylpropyl)nitrous amide

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

O=NN(CCC(C1=CC=CC=C1)C2=CC=CC=C2)CC(C)(O)C

InChI

InChI=1S/C19H24N2O2/c1-19(2,22)15-21(20-23)14-13-18(16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-12,18,22H,13-15H2,1-2H3

Beschreibung

N-(3 | 3-diphenylpropyl)-N-(2-hydroxy-2-methylpropyl)nitrous amide is an N-nitroso derivative of the secondary amine present in Lercanidipine/ N-Nitroso | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Lercanidipine/ N-Nitroso production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.